These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7563546)

  • 21. Haemophilus influenzae type b disease: prospects for prevention in New Zealand.
    Ameratunga SN; Lennon DR; Martin D
    N Z Med J; 1994 May; 107(978):193-4. PubMed ID: 8196862
    [No Abstract]   [Full Text] [Related]  

  • 22. Progress in Haemophilus type b polysaccharide vaccine use in the United States.
    Cochi SL; O'Mara D; Preblud SR
    Pediatrics; 1988 Jan; 81(1):166-8. PubMed ID: 3257297
    [No Abstract]   [Full Text] [Related]  

  • 23. Invasive Haemophilus influenzae serotype B surveillance in Ontario--documenting the progression towards elimination.
    Sciberras J
    Can Commun Dis Rep; 1999 Nov; 25(21):181-4. PubMed ID: 10624034
    [No Abstract]   [Full Text] [Related]  

  • 24. Changing epidemiology of invasive Haemophilus influenzae disease.
    Tsang R
    Lancet Infect Dis; 2008 Dec; 8(12):737. PubMed ID: 19022187
    [No Abstract]   [Full Text] [Related]  

  • 25. Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008.
    MacNeil JR; Cohn AC; Farley M; Mair R; Baumbach J; Bennett N; Gershman K; Harrison LH; Lynfield R; Petit S; Reingold A; Schaffner W; Thomas A; Coronado F; Zell ER; Mayer LW; Clark TA; Messonnier NE
    Clin Infect Dis; 2011 Dec; 53(12):1230-6. PubMed ID: 22080119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemophilus influenzae type B disease control using PENTACEL, Canada, 1998-1999.
    Scheifele D; Halperin S
    Can Commun Dis Rep; 2000 Jun; 26(11):93-6. PubMed ID: 10920538
    [No Abstract]   [Full Text] [Related]  

  • 27. [Significant decline of the number of invasive Haemophilus influenzae infections in the first 4 years after introduction of vaccination against H. influenzae type B in children].
    Conyn-van Spaendonck MA; Veldhuijzen IK; Suijkerbuijk AW; Hirasing RA
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1069-73. PubMed ID: 10850110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of vaccination for Haemophilus influenzae type b.
    Garner D; Weston V
    Lancet; 2003 Feb; 361(9355):395-6. PubMed ID: 12573380
    [No Abstract]   [Full Text] [Related]  

  • 29. Haemophilus influenzae type b diseases in children: a pre-vaccination study.
    Bakir M; el-Khadir A; Devadas K; Farrukh AS; Uduman SA
    East Mediterr Health J; 2001; 7(4-5):597-603. PubMed ID: 15332754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Polysaccharide vaccines against Haemophilus influenzae type B].
    Wysokińska T; Janaszek W
    Przegl Epidemiol; 1994; 48(1-2):39-44. PubMed ID: 8073141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From the Centers for Disease Control and Prevention. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
    JAMA; 1993 May; 269(18):2359. PubMed ID: 8479054
    [No Abstract]   [Full Text] [Related]  

  • 32. Haemophilus influenzae invasive disease in Italy, 1997-1998.
    Ciofi degli Atti ML; Cerquetti M; Tozzi AE; Mastrantonio P; Salmaso S;
    Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):436-7. PubMed ID: 11476451
    [No Abstract]   [Full Text] [Related]  

  • 33. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(11):170-4, 179-80. PubMed ID: 3081787
    [No Abstract]   [Full Text] [Related]  

  • 34. Population-based incidence of invasive haemophilus influenzae and pneumococcal diseases before the introduction of vaccines in Japan.
    Nakamura R; Togashi T
    Pediatr Infect Dis J; 2013 Dec; 32(12):1394-6. PubMed ID: 23804122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of Haemophilus influenzae type b disease in Kentucky. Relationship to immunization, 1988 through 1993.
    Meade BJ; Finger RF; Sosin DM
    J Ky Med Assoc; 1994 Dec; 92(12):490-5. PubMed ID: 7844476
    [No Abstract]   [Full Text] [Related]  

  • 36. Decline in Haemophilus influenzae type B invasive infections at five Canadian pediatric centres.
    Scheifele D; Gold R; Law B; Déry P; Halperin S; Marchessault V; Duclos P
    Can Commun Dis Rep; 1993 Jun; 19(12):88-91. PubMed ID: 8348103
    [No Abstract]   [Full Text] [Related]  

  • 37. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
    CMAJ; 1992 Apr; 146(8):1363-72. PubMed ID: 1555165
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pediatric surveillance of invasive infections caused by Haemophilus influenzae type b in children in the period following introduction of vaccination].
    Conyn-van Spaendonck MA; Suijkerbuijk AW; Hirasing RA; van Pelt W
    Ned Tijdschr Geneeskd; 1995 Apr; 139(17):885-90. PubMed ID: 7739737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemophilus influenzae type B disease, vaccines, and care of exposed individuals.
    Burns IT; Zimmerman RK
    J Fam Pract; 2000 Sep; 49(9 Suppl):S7-13; quiz S14. PubMed ID: 11032188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leads from the MMWR. Update: prevention of Haemophilus influenzae type b disease.
    JAMA; 1986 Apr; 255(15):1990-2. PubMed ID: 3485727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.